VEGFR1/Flt-1 Antibody MAB321-100 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemVEGFR1/Flt-1 Antibody
CompanyR&D Systems, a Bio-Techne Brand
Price $499.00Supplier Page View Company Product Page
Catalog NumberMAB321-100
Quantity100 ug (also 25 ug)
ApplicationsELISA Development,Flow Cytometry,Immunohistochemistry,Western Blot,Neutralization,CyTOF-ready,Cell Culture
Conjugate/TagUnconjugated
ReactivityHuman
TargetVEGFR1/Flt-1
IsotypeIgG1
Clone49560
HostMouse
NCBI Full Gene Namefms related receptor tyrosine kinase 1
NCBI Gene AliasesFLT-1, VEGFR1, FLT, VEGFR-1
ClonalityMonoclonal
FormatLyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS
ImmunogenS. frugiperda insect ovarian cell line Sf 21-derived recombinant human VEGFR1/Flt-1, Ser27-His687, Accession # NP_001153392
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution
Antibody TypePrimary Antibodies
PurityProtein A or G purified from hybridoma culture supernatant

Specifications/Features

Available conjugates: Available conjugates: Unconjugated

Specificity: Detects human VEGFR1/Flt-1 in direct ELISAs and Western blots. In Western blots, this antibody does not cross-react with recombinant mouse VEGFR1, recombinant human (rh) VEGFR2, rhVEGFR3, or rhVEGFR4.

Sizes Available: 100 ug (also 25 ug)

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) The Soluble Fms-like Tyrosine Kinase-1 Contributes to Structural and Functional Changes in Endothelial Cells in Chronic Kidney DiseaseInternational journal of molecular sciencesDecember 16, 2022Schulz A, Drost CC, Hesse B, Beul K, Brand M, Di Marco GS.

(2) Atypical chemokine receptor ACKR3/CXCR7 controls postnatal vasculogenesis and arterial specification by mesenchymal stem cells via Notch signalingCell death & diseaseMay 4, 2020Wei ST, Huang YC, Hsieh ML, Lin YJ, Shyu WC, Chen HC, Hsieh CH.

(3) Synergic effects of VEGF-A and SDF-1 on the angiogenic properties of endothelial progenitor cellsJournal of tissue engineering and regenerative medicineNovember 1, 2017Odent Grigorescu G, Rosca AM, Preda MB, Tutuianu R, Simionescu M, Burlacu A.

(4) Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic ActivityHypertension (Dallas, Tex. : 1979)December 1, 2015Palmer KR, Kaitu'u-Lino TJ, Hastie R, Hannan NJ, Ye L, Binder N, Cannon P, Tuohey L, Johns TG, Shub A, et al.

(5) Vasoreparative dysfunction of CD34+ cells in diabetic individuals involves hypoxic desensitization and impaired autocrine/paracrine mechanismsPloS oneJanuary 1, 2014Jarajapu YP, Hazra S, Segal M, Li Calzi S, Jadhao C, Qian K, Mitter SK, Raizada MK, Boulton ME, Grant MB.

(6) Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cellsNatureJuly 13, 2011Facciabene A, Peng X, Hagemann IS, Balint K, Barchetti A, Wang LP, Gimotty PA, Gilks CB, Lal P, Zhang L, et al.

(7) Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis modelAngiogenesisDecember 1, 2010Brave SR, Eberlein C, Shibuya M, Wedge SR, Barry ST.

(8) Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell linesBMC cancerJune 18, 2010Xu L, Hausmann M, Dietmaier W, Kellermeier S, Pesch T, Stieber-Gunckel M, Lippert E, Klebl F, Rogler G.

(9) Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cellsCancer researchMarch 1, 2009Meissner M, Reichenbach G, Stein M, Hrgovic I, Kaufmann R, Gille J.

(10) Resistance of acute myeloid leukemic cells to the triterpenoid CDDO-Imidazolide is associated with low caspase-8 and FADD levelsLeukemia researchAugust 1, 2008Riccioni R, Senese M, Diverio D, Riti V, Mariani G, Boe A, LoCoco F, Foà R, Peschle C, Sporn M, et al.

(11) Placental growth factor down-regulates type 1 T helper immune response by modulating the function of dendritic cellsJournal of leukocyte biologyDecember 1, 2007Lin YL, Liang YC, Chiang BL.

(12) Expression of Tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blastsStem CellsAugust 1, 2007Riccioni R, Diverio D, Mariani G, Buffolino S, Riti V, Saulle E, Petrucci E, Cedrone M, Lo-Coco F, Foà R, et al.

(13) Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1European journal of clinical investigationOctober 1, 2003Caine GJ, Blann AD, Stonelake PS, Ryan P, Lip GY.

(14) Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesisBloodJanuary 1, 0001"Caldas H, Fangusaro JR, Boué DR, Holloway MP, Altura RA."

Be the First to Write a Review!

VEGFR1/Flt-1 Antibody

VEGFR1/Flt-1 Antibody

VEGFR1/Flt-1 Antibody

VEGFR1/Flt-1 Antibody from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (14)

Reviews

VEGFR1/Flt-1 Antibody from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map